SELLAS Life Sciences (SLS) Property, Plant & Equipment (Net) (2010 - 2017)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 64,489.00
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 116.30 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - 5.32 Mn
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 1.61 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 5.27 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 518.26 Mn
10 SELLAS Life Sciences 1.61 Bn 1.61 Bn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2017 123,000.00
Sep 30, 2017 123,000.00
Jun 30, 2017 148,000.00
Jun 30, 2017 148,000.00
Mar 31, 2017 173,000.00
Mar 31, 2017 173,000.00
Dec 31, 2016 199,000.00
Dec 31, 2016 199,000.00
Sep 30, 2016 226,000.00
Sep 30, 2016 226,000.00
Jun 30, 2016 259,000.00
Jun 30, 2016 259,000.00
Mar 31, 2016 299,000.00
Mar 31, 2016 299,000.00
Dec 31, 2015 335,000.00
Dec 31, 2015 335,000.00
Sep 30, 2015 288,000.00
Sep 30, 2015 288,000.00
Jun 30, 2015 532,000.00
Jun 30, 2015 532,000.00
Mar 31, 2015 528,000.00
Mar 31, 2015 528,000.00
Dec 31, 2014 285,000.00
Dec 31, 2014 285,000.00
Sep 30, 2014 589,000.00
Sep 30, 2014 589,000.00
Jun 30, 2014 623,000.00
Jun 30, 2014 623,000.00
Mar 31, 2014 653,000.00
Mar 31, 2014 653,000.00
Dec 31, 2013 665,000.00
Dec 31, 2013 665,000.00
Sep 30, 2013 545,000.00
Sep 30, 2013 545,000.00
Jun 30, 2013 467,000.00
Jun 30, 2013 467,000.00
Mar 31, 2013 27,000.00
Mar 31, 2013 27,000.00
Dec 31, 2012 29,000.00
Dec 31, 2012 29,000.00
Sep 30, 2012 31,000.00
Sep 30, 2012 31,000.00
Mar 31, 2012 351,000.00
Mar 31, 2012 351,000.00
Dec 31, 2011 393,000.00
Dec 31, 2011 393,000.00
Sep 30, 2011 430,000.00
Sep 30, 2011 430,000.00
Jun 30, 2011 436,000.00
Jun 30, 2011 436,000.00
Dec 31, 2010 419,000.00
Dec 31, 2010 419,000.00